FDA Approves Veklury as First Treatment for COVID-19
The FDA approved Veklury (remdesivir; Gilead Sciences) for the treatment of COVID-19 in patients aged ≥12 years (weighing ≥40kg) requiring hospitalization.
COVID19
MPR Weekly Dose Podcast Episode 55
Results from the survey assessing willingness to receive a COVID vaccine; Dr. Fauci shares that he is ‘cautiously optimistic’ a vaccine could arrive before year’s end; And the breaking news that remdesivir (Veklury) has gained FDA approval.
Moderna: 30,000 Participants Enrolled in COVID-19 Vaccine Trial
The trial is investigating the efficacy, safety, and immunogenicity of mRNA-1273 at the 100mcg dose.
CDC: Number of COVID-19 Deaths May Be Underreported
Only two-thirds of the nearly 300,000 excess deaths in 2020 are attributed to COVID-19.
Tocilizumab Does Not Prevent Intubation, Death in COVID-19
Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients.
Fauci ‘Cautiously Optimistic’ for COVID-19 Vaccine by Year’s End
Fauci was speaking at a virtual meeting of the Infectious Diseases Society of America.c
Discussing Flu and Pneumococcal Vaccines With Patients During COVID-19
Considering COVID-19 has dominated the news all across the world, some people could have been distracted from other medical concerns that exist. And as flu season approaches, getting vaccinated is still something patients need to prioritize. Health officials in the United States have urged Americans to get influenza and pneumococcal vaccines, but recent data from…
Survey Reveals Factors Contributing to COVID-19 Vaccine Acceptance
To estimate the association between attribute level and probability of choosing and receiving a vaccine, the study authors calculated the average marginal component effects sizes as well as marginal means.
Diabetes Increases Risk of In-Hospital Mortality in Patients With COVID-19
Hospitalized patients with severe COVID-19 and diabetes are less likely to be discharged from the hospital and are more likely to experience in-hospital mortality compared with patients without diabetes.
Scientists to Infect Volunteers With COVID-19 in Challenge Trial
Challenge trials have long history, going back to development of smallpox vaccine in 1796.
